
Bree Coven Foster
Editor, Marketing and Public Service Initiatives at Seattle Times
Articles
-
2 weeks ago |
drugdiscoverynews.com | Bree Coven Foster
As microfluidics continue to gain ground as a critical enabler of single-cell research and therapeutic development, companies at the forefront of the field are evolving to meet growing demand for scalable, integrated solutions.
-
4 weeks ago |
drugdiscoverynews.com | Bree Coven Foster
Synthetic DNA is increasingly used for gene therapies due to its fast production and improved scalability compared to traditional plasmid-based methods. Credit: iStock.com/ktsimageSynthetic DNA is increasingly used for gene therapies due to its fast production and improved scalability compared to traditional plasmid-based methods.
-
1 month ago |
drugdiscoverynews.com | Bree Coven Foster
In the world of drug development, securing timely access to fill/finish services can often pose a critical bottleneck, especially for clinical trials requiring small-volume production. Fill/finish refers to the final steps in the production of injectable pharmaceutical drug substances, including the process of filling vials with a drug substance, sealing them, and ensuring they are sterile and ready for use in clinical settings.
-
1 month ago |
drugdiscoverynews.com | Bree Coven Foster
Duchenne muscular dystrophy (DMD) has long been understood as a disease driven by the absence of dystrophin, a protein essential for maintaining muscle integrity. Most therapeutic efforts have focused on restoring dystrophin through gene therapy, exon-skipping, or other genetic approaches. However, emerging research suggests that dystrophin’s role extends beyond structural support — it also plays a critical part in regulating muscle regeneration.
-
1 month ago |
drugdiscoverynews.com | Bree Coven Foster
From understanding immune responses to screening new drug candidates, flow cytometry plays a critical role in modern biomedical research. By rapidly analyzing thousands of cells per second, researchers can gather precise, multiparametric data at the single-cell level. Recent innovations in automation and high-throughput screening have further expanded the technology’s potential, making it a powerful tool for drug discovery.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →